ADTX - Aditxt Inc
IEX Last Trade
0.638
0.059 9.248%
Share volume: 251,875
Last Updated: Fri 30 Aug 2024 09:35:15 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$0.58
0.06
10.19%
Fundamental analysis
33%
Profitability
50%
Dept financing
50%
Liquidity
1%
Performance
20%
Performance
5 Days
-28.46%
1 Month
-46.04%
3 Months
-67.07%
6 Months
-81.39%
1 Year
-93.45%
2 Year
-99.79%
Key data
Stock price
$0.64
DAY RANGE
N/A - N/A
52 WEEK RANGE
$0.56 - $43.75
52 WEEK CHANGE
-$0.98
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
Company detail
CEO:
Region: US
Website:
Employees: 42
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website:
Employees: 42
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
a biotech company with a mission to accelerate humanity’s transition to the "age of immunity", we are the business busily decoding the human immune system.
Recent news